Weihua D. Xiao

Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Development of a novel hydroxylated recombinant human type III collagen TD-1-HrHC in Komagataella phaffii with transdermal and skin damage repair activity.

Development of a novel hydroxylated recombinant human type III collagen TD-1-HrHC in Komagataella phaffii with transdermal and skin damage repair activity.

Journal: Microbial cell factories

Published: March 09, 2026

Machine learning-based development of a cytotoxicity prediction model for NK cell therapy in cancers.

Machine learning-based development of a cytotoxicity prediction model for NK cell therapy in cancers.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 10, 2025

Enhanced efficacy of gastric cancer treatment by a combination of NK cells and chemotherapy.

Enhanced efficacy of gastric cancer treatment by a combination of NK cells and chemotherapy.

Journal: iScience

Published: March 04, 2025

Endolysosomal channel TMEM175 mediates antitoxin activity of DABMA.

Endolysosomal channel TMEM175 mediates antitoxin activity of DABMA.

Journal: The FEBS journal

Published: November 12, 2023

Anti-Melanogenic and Antioxidant Activity of Bifidobacterium longum Strain ZJ1 Extracts, Isolated from a Chinese Centenarian.

Anti-Melanogenic and Antioxidant Activity of Bifidobacterium longum Strain ZJ1 Extracts, Isolated from a Chinese Centenarian.

Journal: International journal of molecular sciences

Published: June 30, 2023

Development of an antibody-ligand fusion protein scFvCD16A-sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells.

Development of an antibody-ligand fusion protein scFvCD16A-sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells.

Journal: Microbial cell factories

Published: December 12, 2022

Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer.

Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer.

Journal: Cancers

Published: September 20, 2021

Energy restriction causes metaphase delay and chromosome mis-segregation in cancer cells.

Energy restriction causes metaphase delay and chromosome mis-segregation in cancer cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 28, 2021

Advances in NK cell production.

Advances in NK cell production.

Journal: Cellular & molecular immunology

Published: May 11, 2021

Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Journal: Cellular & molecular immunology

Published: May 04, 2021

Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.

Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.

Journal: Journal of hematology & oncology

Published: March 16, 2021

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity.

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity.

Journal: Nature immunology

Published: February 27, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026